FDA New York field office, Office of Regulatory Affairs. Credit: CaptJayRuffins.

Caption Health has secured authorisation from the US Food and Drug Administration (FDA) to market its cardiac ultrasound software.

The software, Caption Guidance, enables medical professionals to acquire cardiac ultrasound images. It leverages artificial intelligence (AI) to offer real-time guidance and diagnostic quality assessment of images to the healthcare providers.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

FDA approved the software through De Novo pathway after reviewing performance testing and data from a multi-centre prospective clinical trial.

Now indicated for use in ultrasound heart examination, Caption Guidance is effective in procuring standard views of the heart from different angles, used to diagnose various cardiac conditions.

FDA Office of In Vitro Diagnostics and Radiological Health deputy director Robert Ochs said: “Today’s marketing authorization enables medical professionals who may not be experts in ultrasonography, such as a registered nurse in a family care clinic or others, to use this tool.

“This is especially important because it demonstrates the potential for artificial intelligence and machine learning technologies to increase access to safe and effective cardiac diagnostics that can be life-saving for patients.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Initially, deployed in acute point-of-care settings such as emergency and anesthesiology departments and critical care units, the software’s usage will soon be expanded to other departments.

Caption Health co-founder and president Charles Cadieu said: “We founded Caption Health to tackle head-on some of the most challenging, intractable problems in medicine.

“This FDA authorisation confirms our unique ability to couple breakthrough technology with robust clinical validation.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact